SpringFire Laboratory Network has added Atherotech Diagnostics Lab to its network of affiliate laboratories. The network provides specialized testing services to clinical trial sponsors and CROs. The agreement adds Atherotech’s cardiometabolic testing services, including the patented VAP (Vertical Auto Profile) advanced lipid profile, to SpringFire’s offering of more than 1,000 specialty tests.

“We are very excited about the addition of Atherotech to the SpringFire network of laboratories,” said Jim McClintic, managing partner of SpringFire Laboratory Network. “The marketplace is in need of additional experienced esoteric laboratories to meet the growing demand for clinical research services.” He noted that high complexity laboratories such as Atherotech are in great demand in the clinical trials market.

Atherotech offers researchers more than 50 CV and metabolic tests and is the only laboratory that performs the VAP Cholesterol Test, a directly measured assessment of all major lipoprotein classes (HDL, LDL, VLDL, IDL and Lp(a)) and their important subclasses, including HDL2, HDL3, LDL1 – LDL4, apoB, apoA1 and the apoB/apoA1 ratio. The VAP profile also provides LDL subclass pattern (A, A/B or B) and remnant lipoprotein cholesterol.

“This partnership will further expose the VAP Test to the clinical trial marketplace,” said Michael Mullen, Atherotech’s chief executive officer. “SpringFire’s experience in business development and customer service with both clinical trial sponsors and CROs will be an asset to Atherotech as we focus on promoting accurate, directly measured lipid testing.”